Literature DB >> 1415576

Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia.

C C Tan1, K U Eckardt, J D Firth, P J Ratcliffe.   

Abstract

Erythropoietin (EPO) mRNA levels were measured by ribonuclease (RNase) protection in organs from unstimulated rats and from animals after normobaric hypoxia or hemorrhagic anemia. Both liver and kidney responded to stimulation with large increases in EPO mRNA, but the response characteristic to graded stimulation was different. The liver responded poorly to mild normobaric hypoxia, accounting for only 2 +/- 1% of total EPO mRNA at 11% O2, but hepatic EPO mRNA levels increased steeply with more severe hypoxia so that at 7.5% O2 the liver contributed to 33 +/- 7% of the total. After hemorrhagic anemia, the liver also responded more strongly to more severe stimulation, but at all points it accounted for a significant proportion of total EPO mRNA, contributing 18 +/- 6% after removal of 2.5 ml (hematocrit 37.2 +/- 1.3%), increasing to 37 +/- 14% after venesection of 10.5 ml (hematocrit 15.8 +/- 0.8%). Studies of EPO mRNA in other organs confirmed that EPO production outside the liver and kidney were quantitatively insignificant in stimulated animals. However, the hypoxia-induced increases in EPO mRNA in brain, testis, and spleen suggest the existence of an oxygen-sensing mechanism at other sites.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1415576     DOI: 10.1152/ajprenal.1992.263.3.F474

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  44 in total

Review 1.  Oxygen delivery enhancers: past, present, and future.

Authors:  P Borrione; A Mastrone; R A Salvo; A Spaccamiglio; L Grasso; A Angeli
Journal:  J Endocrinol Invest       Date:  2008-02       Impact factor: 4.256

Review 2.  The neurobiology of erythropoietin.

Authors:  Arthur J Sytkowski
Journal:  Cell Mol Neurobiol       Date:  2011-05-03       Impact factor: 5.046

3.  Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia.

Authors:  Pinelopi P Kapitsinou; Qingdu Liu; Travis L Unger; Jennifer Rha; Olena Davidoff; Brian Keith; Jonathan A Epstein; Sheri L Moores; Connie L Erickson-Miller; Volker H Haase
Journal:  Blood       Date:  2010-07-13       Impact factor: 22.113

4.  Divergent regulation of vascular endothelial growth factor and of erythropoietin gene expression in vivo.

Authors:  P Sandner; B Gess; K Wolf; A Kurtz
Journal:  Pflugers Arch       Date:  1996-04       Impact factor: 3.657

5.  William Kaelin, Peter Ratcliffe, and Gregg Semenza receive the 2016 Albert Lasker Basic Medical Research Award.

Authors:  Jillian H Hurst
Journal:  J Clin Invest       Date:  2016-09-13       Impact factor: 14.808

Review 6.  Stimulating erythropoiesis in inflammatory bowel disease associated anemia.

Authors:  Georgia Tsiolakidou; Ioannis-E Koutroubakis
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

Review 7.  Use of agents stimulating erythropoiesis in digestive diseases.

Authors:  Rosario Moreno López; Beatriz Sicilia Aladrén; Fernando Gomollón García
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

Review 8.  Differentiating factors between erythropoiesis-stimulating agents: a guide to selection for anaemia of chronic kidney disease.

Authors:  Robert Deicher; Walter H Hörl
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Regulation of clock-controlled genes in mammals.

Authors:  Katarzyna Bozek; Angela Relógio; Szymon M Kielbasa; Markus Heine; Christof Dame; Achim Kramer; Hanspeter Herzel
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

10.  The protective effect of erythropoietin infusion on testicular torsion/detorsion: an experimental study.

Authors:  Burhan Köseoğlu; Engin Yilmaz; Kadir Ceylan; Ersan Uzun; Irfan Bayram; Fatih Hizli
Journal:  Int Urol Nephrol       Date:  2008-07-15       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.